DTx Clinical Trials: Interoperability and the Power of Remote Trial Designs

Tech-enabled, hybrid clinical trial designs can be extremely advantageous for digital therapeutics (DTx) studies. As DTx interventions are typically deployed in chronic conditions and home settings, remote trial designs and approaches are ideal for DTx.

In this webinar, Castor experts discuss the importance of prioritizing an integrated patient experience and the power of interoperability in DTx clinical trials. By carefully architecting the interplay between a sponsor’s DTx technology and their eClinical infrastructure, the cost of launching and conducting subsequent trials can be greatly reduced, while maximizing the patient experience.

What you’ll learn:

• How to create an integrated patient experience by leveraging the right eClinical technology
• Strategies to implement a lightweight patient experience and considerations for study design to accelerate deployment
• In depth review of real-world case studies that reduced trial timelines and cost by optimizing both the site and patient experience

Speakers

Kimberly Tableman, Chief Clinical Development Officer, Castor

Kimberly Tableman is Chief Clinical Development Officer (CCDO) at Castor. She has more than 23 years of experience in clinical development and technology. Over the past decade, she has focused on applying digital health technologies to reimagine the patient journey. She was most recently CEO at Medicine X, and co-founder at Rabble Health, where she led the development and beta launch of a patient engagement platform to serve oncology patients. Prior to Medicine X, Kimberly held senior roles at GlaxoSmithKline (GSK), including Head of Patient Engagement and Head of Digital Clinical Trials. She has also worked at Pfizer, and began her career in management consulting at Cap Gemini Ernst & Young.

Message Presenter

Sabrina R. Taylor, PhD, CCRP, Head of Clinical Trials, MedRhythms

Dr. Taylor is Head of Clinical Trials at MedRhythms, a leading next-generation digital therapeutics company. She has more than 10 years of experience in research, with expertise in clinical trial project management. Prior to MedRhythms, she was Director of Clinical Studies at the University of California San Francisco Brain and Spinal Injury Center (BASIC). There, she maintained a clinical research trial network of more than 20 clinical trial sites, all Level 1 trauma centers, for several national, multicenter clinical research initiatives, including the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) network. Sabrina was also a Research Coordinator in the Neurorehabilitation Laboratory at Spaulding Rehabilitation Hospital, one of the nation’s top rehabilitation centers, where she coordinated the Traumatic Brain Injury Model System (TBIMS) and other projects. She received her B.S. in Neuroscience at Stonehill College and her Ph.D. in Experimental and Molecular Medicine (Neuroscience) at Dartmouth College.

Message Presenter